• NIDA HIV Seminar Series: July 31, 2024, 1pm ET

    NIDA HIV Seminar Series: Social & Political Determinants of HIV Among People Who Use Drugs (July 31, 1pm ET)

    Join Dr. Ricky Bluthenthal, PhD, on July 31, 2024 (1-2pm ET) for the next NIDA HIV Seminar! Dr. Bluthenthal is a Distinguished Professor of Population and Public Health Sciences at the Keck School of Medicine at the University of Southern California. He conducts community-partnered research at the intersection of harm reduction and health disparities among people who use drugs. In this session, Dr. Bluthenthal will talk about social and political determinants of HIV among people who use drugs. Register for the seminar here!

  • Opioid Clinical Decision Support in Primary Care: CTN-0095 webinar June 26, 2024

    Webinar: Opioid Clinical Decision Support in Primary Care: CTN-0095 (1.5 CME/CE; June 26, 2024)

    Join the Western States Node of the CTN and the Northwest and Pacific Southwest ATTCs for their next joint webinar, coming June 26, 2024, 11am-12:30pm PT! In this session, Opioid Clinical Decision Support in Primary Care: CTN-0095, presenters Stephanie Hooker, PhD, MPH (HealthPartners Institute), and Rebecca Rossom, MD, MS (HealthPartners Institute and PI of the CTN NorthStar Node), will discuss the design and implementation of Opioid Wizard, a clinical decision support tool embedded in the EHR for primary care clinicians. The goal of the Opioid Wizard tool is to help clinicians identify, screen, diagnose and treat opioid use disorder (OUD). They will also discuss one of the supplements to CTN…

  • Artificial Intelligence in Medicine & Imaging (AIMI) Symposium 2024 (May 15, Free, @ Stanford and Online)

    Machine learning and artificial intelligence are redefining the boundaries of medicine, unleashing potential like never before to ensure better health for all. Sponsored by the Stanford University Center for Artificial Intelligence in Medicine & Imagining (AIMI), the FREE AIMI Symposium serves as their flagship annual meeting, focusing on the pioneering developments and significant strides in AI that are shaping the future of healthcare. They will highlight cutting-edge research and methods, showcase current and emerging real-world clinical applications, and address critical issues related to fairness and societal impact.  This symposium serves as a pivotal forum for researchers, clinicians, policymakers, and anyone passionate about the future of healthcare to confront existing challenges,…

  • AHSR 2024

    AHSR 2024: Abstract Submission Deadline Extended to May 10!

    AHSR is still accepting individual presentation and symposium abstracts for innovative and impactful research that moves the field of addiction forward. Abstracts must be submitted by the person who intends to present the study in the case of an individual presentation, and by the chair/moderator in the case of a symposium session. We anticipate that accepted abstracts will be published in a peer-reviewed journal. The deadline for all submissions is Friday, May 10, 2024, at 11:59 PM PT. The AHSR Early Career Investigator Award recognizes scholars with early achievements and exceptional promise for future contributions to addiction health services research. Continuing the tradition of recognizing and supporting the next generation of researchers, we will select up to…

  • AHSR 2024

    Addiction Health Services Research (AHSR) Conference 2024: Oct. 16-18

    The Addiction Health Services Research (AHSR) conference, held since 2005, brings together researchers, policymakers, and treatment providers to solve the problems of inequity, access, effectiveness, and implementation of addiction services. This conference has been hosted across the United States at leading institutions, including Weill Cornell Medicine, Brandeis University, the University of Utah School of Medicine, Brown University, and more. This year, the conference is hosted by the Center for Dissemination and Implementation (CDI), a Stanford University initiative, at the historic Palace Hotel in the beautiful and bustling city of San Francisco, near quintessential landmarks including the cable cars and Chinatown. The AHSR website is now live and registration is open!

  • Quarterly SC Meeting

    CTN Quarterly Steering Committee Meeting, April 16 – Updated start time: 2:45pm ET

    The next Clinical Trials Network (CTN) Quarterly Steering Committee Meeting will be held virtually on Tuesday, April 16, 2024, from 2:45 p.m.– 5:00 p.m. ET. Note: this is an updated start time! Join using this link | Download agenda If you would like to be added to the calendar invitation please email ctnsupport@leedmci.com. Also, while we will not convene in person this Spring, we are excited to announce our next in-person meeting will be held in the Fall of 2024 to coincide with the CTN 25th Anniversary. Please stay tuned for a formal announcement soon with the dates and location.

  • Science Series April 2024

    Northeast Node Webinar: Emergency Department Initiation of Alcohol Use Disorder Treatment (April 25, 2024, 12pm ET)

    In this session, Javad S. Mashkuri, MD (Central Vermont Medical Center) will review protocols for emergent treatment of Alcohol Use Disorder (AUD) in the Emergency Department (ED), discuss linkage and coordination of AUD care from ED to outpatient settings, discuss the role of peer recovery/ED care management in care planning and transitions, and will utilize case studies to illustrate the Refocus on Alcohol Dependence (ROAD) experience. Connect to Zoom (meeting ID & link): 919 7631 6490Passcode: 870392April 25, 2024 | 12-1pm ET 1 AMA PRA Category 1 CME Credit available. About the presenter As an emergency department (ED) physician, Dr. Mashkuri has a special interest in low barrier access to…

  • CTN Primary Care SIG

    Primary Care SIG Virtual Meeting: Are We There Yet? 25 Years of Research on Treating OUD In Primary Care – March 25, 9-10am PT

    The Practice-Based Research Network (PBRN) SIG is shifting focus to be the Primary Care SIG.  They meet every other month on the fourth Monday at 9 am PT/noon ET.  Please spread the word that all interested people are welcome to join! The next meeting will be Monday, March 25. Dr. David Fiellin is presenting.  Here are the login details: Primary Care SIG webinar on March 25th from 9-10am PDT/12-1pm EDT TOPIC: “Are we there yet? 25 years of research on treating OUD in primary care.”  SPEAKER: David Fiellin, MD Professor of Medicine, Emergency Medicine and Public Health Vice Chief, Faculty Affairs, General Internal Medicine Director, Program in Addiction Medicine Yale School of Medicine  Please join the webinar here (no registration required):Passcode: 201068 Interested in presenting at a future Primary Care SIG meeting? Email…

  • HIV Seminar Series, April 17, 2024

    NIDA HIV Research Program Seminar: Novel Neurogenomic Techniques to Explore HIV in the Brain (April 17, 10am PT)

    Join NIDA’s next HIV Research Program Seminar on April 17, 2024 at 10am PT, with our Avant-Garde Award recipient Dr. Schahram Akbarian, Professor of Psychiatric Epigenomics at Mount Sinai. Dr. Akbarian will present a talk on “Novel Neurogenomic Techniques to Explore #HIV in the Brain.” Dr. Akbarian’s laboratory explores the neurogenomics of HIV and drug use in human and mouse brains, including single-molecule and single-cell technologies.  Download flyer | Register here

  • CTN/ ATTC webinar: Cannabis and Mental Health

    CTN WS Node / ATTC Webinar: Cannabis and Mental Health (Feb 28, 11am PT)

    The CTN Western States Node and the Northwest and Pacific Southwest ATTCs are hosting their next joint webinar on February 28, 2024, from 11am-12:30pm PT. In this session, Natania Crane, PhD, Assistant Professor of Psychiatry and Associate Director of the UIC Recovery Clinic, will provide current information on research and treatment related to cannabis use and mental health, including recent changes in cannabis use, how the endocannabinoid system may regulate mental health symptoms, and what we currently know about cannabis use and mental health. Dr. Natania Crane’s research uses multiple methods (i.e., fMRI, EEG, cognitive, clinical, and self-report measures) to examine the brain and behavioral risk factors and consequences of substance…